7617-70-1

Basic information

• Product Name: Benzaldehyde, 4-(2-bromoethyl)-
• CAS NO: 7617-70-1
• Molecular Formula: C9H9BrO
• Molecular Weight: 213.074
• Mol File: 7617-70-1.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-(2-bromoethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-(2-bromoethyl)-(7617-70-1)
• EPA Substance Registry System: Benzaldehyde, 4-(2-bromoethyl)-(7617-70-1)

Safety Data

• Hazardous Substances Data: 7617-70-1(Hazardous Substances Data)

Upstream product

• 24249-98-7 p-chloromethyl-2-bromoethylbenzene 
• 52062-92-7 4-(2-bromoethyl)benzoic acid 
• 4885-02-3 Dichloromethyl methyl ether 
• 103-63-9 1-phenyl-2-bromoethane 
• 5312-73-2 dichloromethyl n-butyl ether 

Downstream Products

• 52062-92-7 4-(2-bromoethyl)benzoic acid 
• 72054-56-9 4-(2-bromoethyl)benzonitrile 
• 1622143-73-0 1-(2-chloroethyl)-4-(dimethoxymethyl)benzene 
• 1622143-72-9 1-(2-bromoethyl)-4-(dimethoxymethyl)benzene 
• 934753-51-2 ethyl 8-(4-cyanophenyl)-6-formyloctanoate 
• 934737-83-4 methyl 4-[4-(4-cyanophenyl)-2-formylbutyl]benzoate 
• 934753-50-1 ethyl 8-(4-cyanophenyl)-6-hydroxymethyloctanoate 
• 934737-82-3 methyl 4-[4-(4-cyanophenyl)-2-hydroxymethylbutyl]benzoate 
• 934753-49-8 2-[2-(4-cyanophenyl)ethyl]heptanedioic acid 7-ethyl ester 
• 934737-81-2 methyl 4-[2-carboxy-4-(4-cyanophenyl)butyl]benzoate 
• 934753-05-6 methyl (E)-4-[2-[2-(4-cyanophenyl)ethyl]-4-(2-hydroxyphenyl)but-3-enyl]benzoate 
• 934753-52-3 ethyl E-6-[2-(4-cyanophenyl)ethyl]-8-(2-hydroxyphenyl)oct-7-enoate 
• 934753-48-7 1-Allyl 7-ethyl 2-allyloxycarbonyl-2-[2-(4-cyanophenyl)ethyl]heptandioate 
• 934737-79-8 diallyl 2-[2-(4-cyanophenyl)ethyl]-2-(4-methoxycarbonylbenzyl)malonate 

Relevant articles and documents

KINASE MODULATORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

Provided herein are kinase modulators, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disease, disorder, or condition associated with a protein malfunction.

SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS

The present invention relates to substituted diaryl azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.

Dicarboxylic Acid Derivatives and their Use

The present application relates to novel dicarboxylic acid derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, es